XML 73 R57.htm IDEA: XBRL DOCUMENT v3.25.0.1
INVESTMENT IN REAL ESTATE PROPERTIES - Summarized Financial Information for Enlivant Joint Venture (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Balance Sheet Amounts      
Total assets $ 5,303,679 $ 5,386,150  
Total liabilities 2,562,391 2,583,616  
Income Statement Amounts      
Total revenues 703,235 647,514 $ 624,811
Other-than-temporary impairment 0 0 57,778
Loss from unconsolidated joint venture (397) (2,897) (98,032)
Enlivant Joint Venture      
Income Statement Amounts      
Company’s share of net loss (397) (2,897) (32,581)
Basis adjustments 0 0 7,673
Other-than-temporary impairment 0 0 57,778
Loss from unconsolidated joint venture (397) (2,897) (98,032)
Enlivant Joint Venture      
Balance Sheet Amounts      
Total assets 313,480 353,779  
Total liabilities 97,722 106,490  
Member’s equity 215,758 247,289  
Income Statement Amounts      
Total revenues 70,615 64,446 351,073
Operating expenses 49,455 47,811 324,462
Net loss $ (5,559) $ (9,823) (66,171)
Funding payments beyond contractual requirements     $ 25,000